Audit 370077

FY End
2024-12-31
Total Expended
$4.04M
Findings
17
Programs
12
Organization: The Scintillon Institute (CA)
Year: 2024 Accepted: 2025-09-30
Auditor: Leaf & Cole LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1158152 2024-001 Material Weakness Yes C
1158153 2024-001 Material Weakness Yes C
1158154 2024-001 Material Weakness Yes C
1158155 2024-001 Material Weakness Yes C
1158156 2024-001 Material Weakness Yes C
1158157 2024-001 Material Weakness Yes C
1158158 2024-001 Material Weakness Yes C
1158159 2024-001 Material Weakness Yes C
1158160 2024-001 Material Weakness Yes C
1158161 2024-001 Material Weakness Yes C
1158162 2024-001 Material Weakness Yes C
1158163 2024-001 Material Weakness Yes C
1158164 2024-001 Material Weakness Yes C
1158165 2024-001 Material Weakness Yes C
1158166 2024-001 Material Weakness Yes C
1158167 2024-001 Material Weakness Yes C
1158168 2024-001 Material Weakness Yes C

Programs

Contacts

Name Title Type
WAADZMTALN67 Erica Chavin Auditee
8586579145 Jill Branch Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of The Scintillon Institute under programs of the federal government for the year ended December 31, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of The Scintillon Institute, it is not intended to and does not present the financial position, changes in net assets, or cash flows of The Scintillon Institute.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Pass-through entity identifying numbers are presented where available. The Scintillon Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance.

Finding Details

Condition Funds were drawn down by the Institute in excess of the three-day period recommended by its funding agency, and did not minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient during the year ended December 31, 2024. Criteria Cash management under 2 CFR 215.22 states that payment methods shall minimize the time elapsing between the transfers of funds from the grantor to the issue of payment by the recipient. Cause The Institute’s preparation and review procedures over the draw-down of funds were insufficient to minimize the time elapsing between the transfers of funds from the grantor to the issue of payments by the Institute. Effect The Institute was not in compliance with the cash management compliance requirements stated in 2 CFR 215.22 during the year. Recommendation The Institute should improve policies and procedures regarding cash management. This should include the procedure for calculating the allowable cash draw for actual immediate cash needs for expenses to be paid within the three-day period, in order to minimize the time elapsing between the transfer of funds from the grantor to the issue of payment by the recipient to cover operating cash flow needs. Views of Responsible Officials and Planned Corrective Actions Management acknowledges the finding and the management staff of the Institute take seriously the federal compliance requirements that apply to drawing funds from the DHHS Payment Management System. The Institute recognizes that it has drawn down excess funds. The Institute plans to improve policies and procedures for cash management in 2025 that will ensure the calculation for allowable cash draw for actual immediate cash needs is complete and accurate.